|
|||||
|
|
Establishment of a hepatocellular carcinoma patient-derived xenograft platform and its application in biomarker identification |
|
| Authors: | Bo Hu Hong Li Wei Guo Yun-Fan Sun Xin Zhang Wei-Guo Tang Liu-Xiao Yang Yang Xu Xiao-Yan Tang Guo-Hui Ding Shuang-Jian Qiu Jian Zhou Yi-Xue Li Jia Fan Xin-Rong Yang |
| Affiliation: | 1. Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, People's Republic of China Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China;2. Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, People's Republic of China;3. Key Laboratory of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China;4. Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, People's Republic of China Institute of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China;5. Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China |
| Abstract: | |
| Keywords: | hepatocellular carcinoma patient-derived tumor grafts sorafenib drug resistance MAP3K1 |